COMMUNIQUÉS West-GlobeNewswire

New Study Identifies Successful Approaches to Antimicrobial Stewardship Programs in U.S. Hospitals

25/01/2018 - 19:00

OAKBROOK TERRACE, Ill., Jan. 25, 2018 (GLOBE NEWSWIRE) -- Misuse of antibiotics can lead to antibiotic resistance, accounting for more than two million infections and 23,000 deaths annually in the United States. 1 To [...]

IBA SA : IBA - TRANSPARENCY NOTIFICATION

25/01/2018 - 18:01

IBA - TRANSPARENCY NOTIFICATION Louvain-la-Neuve, Belgium, January 25, 2018, 17.35 - IBA (Ion Beam Applications SA), the world's leading provider of proton therapy solutions for the treatment of cancer, announces that [...]

IBA SA : IBA - NOTIFICATION DE TRANSPARENCE

25/01/2018 - 18:01

IBA - NOTIFICATION DE TRANSPARENCE Louvain-la-Neuve, Belgique, 25 janvier 2018, 17.35 - IBA (Ion Beam Applications SA), le premier fournisseur mondial de solutions de protonthérapie pour le traitement du cancer, annonce [...]

Expert Panel Brings New Approach to Challenges of Aging in Rural America

25/01/2018 - 18:00

WASHINGTON, Jan. 25, 2018 (GLOBE NEWSWIRE) -- Academic, business, and healthcare leaders from across the country gathered today at the Newseum in Washington, D.C. to bring focus to a new approach to solving the [...]

OSE Immunotherapeutics Receives Notice of Allowance for New Patent by U.S. Patent and Trademark Office that Further Strengthens Intellectual Property Portfolio Around Tedopi® in Immuno-Oncology Applications

25/01/2018 - 18:00

NANTES, France, Jan. 25, 2018 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics (ISIN:FR0012127173) (Mnémo:OSE), today announces that it has received a notice of allowance from the U.S. Patent and Trademark Office (USPTO) for [...]

ProMIS Neurosciences to Present at Upcoming Investor Conferences

25/01/2018 - 17:22

TORONTO and CAMBRIDGE, Mass., Jan. 25, 2018 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc., a biotechnology company focused on the discovery and development of precision treatments for neurodegenerative diseases, today [...]

Exagen Diagnostics announces collaboration with GSK to drive greater awareness about challenges facing lupus diagnosis and management

25/01/2018 - 17:05

ALBUQUERQUE, NM and SAN DIEGO, CA, Jan. 25, 2018 (GLOBE NEWSWIRE) -- Exagen Diagnostics, Inc. today announced a first-of-its kind collaboration with GSK to raise awareness of its laboratory tests, which facilitate early [...]

Nextech Highlights NexCloud for Medical Spas at the American Med Spa Association Show

25/01/2018 - 17:01

TAMPA, Fla., Jan. 25, 2018 (GLOBE NEWSWIRE) -- Nextech Systems , a leading provider of health care technology solutions for specialty physician practices, will present its leading aesthetic medicine cloud technology for [...]

Zealand Pharma hosts Capital Market Day: Accelerating the late stage pipeline

25/01/2018 - 17:01

Press release - No. 2/2017 Zealand Pharma hosts Capital Market Day: Accelerating the late stage pipeline Four late stage programs with best-in-class potential and attractive risk profiles for rare diseases and diabetes [...]

ArmadaCare Appoints New Vice President of National Accounts

25/01/2018 - 17:00

BALTIMORE, Md., Jan. 25, 2018 (GLOBE NEWSWIRE) -- ArmadaCare, a supplemental insurance company, recently appointed Matthew Mattice to its newly created position, Vice President of National Accounts, to help address the [...]

Woebot Labs Launches Mobile App for iOS - Expanding Reach and Capability of Mental Health Chatbot

25/01/2018 - 17:00

SAN FRANCISCO, Jan. 25, 2018 (GLOBE NEWSWIRE) -- Woebot Labs, Inc. today launched Woebot for iOS on the Apple iTunes Store. Woebot is the only mental health chatbot that is clinically shown to reduce symptoms of mood- [...]

Tempus and NYU School of Medicine Announce New Initiative to Help Improve Outcomes for Pancreatic Cancer Patients

25/01/2018 - 16:30

CHICAGO, Jan. 25, 2018 (GLOBE NEWSWIRE) -- Tempus, a technology company focused on helping doctors personalize cancer care by collecting and analyzing large volumes of molecular and clinical data, today announced a [...]

UPDATE -- DLT Resolution to acquire 80% of fast growing Canadian start-up A.J.D. Data Services Ltd.

25/01/2018 - 16:18

LAS VEGAS, NV, Jan. 25, 2018 (GLOBE NEWSWIRE) -- DLT Resolution Inc. (OTC: DLTI), a blockchain technology and data services company providing distributed ledger technology that currently services the healthcare and [...]

Mariner Endosurgery Receives Health Canada Investigational Testing Approval for LaparoGuard Technology

25/01/2018 - 16:00

Hamilton, Jan. 25, 2018 (GLOBE NEWSWIRE) -- Mariner Endosurgery Inc., an innovative Canadian medical device company leading commercialization of computer-assisted medical devices for laparoscopic surgeries, announced [...]

American Gene Technologies Announces Progress toward Phase I Clinical Trial of AGT103-T for HIV Functional Cure

25/01/2018 - 15:30

ROCKVILLE, Md., Jan. 25, 2018 (GLOBE NEWSWIRE) -- American Gene Technologies International Inc. (AGT), a leading gene and cell therapy company, today announced completion of the pilot runs of its HIV Functional Cure [...]

UPDATE -- Breathtec Biomedical Provides Development Update on Breathalyzer for Disease Detection

25/01/2018 - 15:27

VANCOUVER, British Columbia, Jan. 25, 2018 (GLOBE NEWSWIRE) -- Please note this is an Official Company News Release. Breathtec Biomedical Inc. (CSE:BTH) (CNSX: BTH ) (FRANKFURT: BTI ) (OTCQB:BTHCF) (the “Company”) is [...]

Zosano Announces Results of Special Meeting of Stockholders and 1-for-20 Reverse Stock Split

25/01/2018 - 15:00

FREMONT, Calif., Jan. 25, 2018 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ: ZSAN ) (“Zosano” or the “Company”) a clinical-stage biopharmaceutical company focused on providing rapid systemic administration of [...]

ArmadaCare Announces a New Suite of Supplemental Insurance Products

25/01/2018 - 15:00

HUNT VALLEY, Md., Jan. 25, 2018 (GLOBE NEWSWIRE) -- ArmadaCare has launched a new suite of supplemental insurance products, further strengthening its market-leading position in the group targeted supplemental health [...]

Novan Announces First Patient Dosed in Phase 2 Molluscum Contagiosum Trial with SB206

25/01/2018 - 15:00

MORRISVILLE, N.C., Jan. 25, 2018 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (NASDAQ: NOVN ) today announced that the first patient has been dosed in the Company's Phase 2 clinical trial to evaluate [...]